Shots are pretty much the oldest health tech in the book, but vaccines remain an important tool to help people stay healthy ...

The U.S. Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its standalone flu vaccines, the company said on Monday.

This year’s flu shot will be missing a strain of influenza ... In contrast, SARS-CoV-2 was a brand new virus that no one had encountered before; therefore, masking and isolation only slowed ...

Meet the experts: Thomas Russo, M.D., professor and chief of infectious disease at the University at Buffalo in New York ...

New research shows that some strains of influenza may now be extinct following the pandemic, but health professionals stress ...

Novavax is already poised to benefit from a separate combined Covid-flu vaccine via a deal with Sanofi announed earlier this year. Under the $1.4 billion co-licensing agreement, announced in May, ...

Opens in a new tab or window Data from the southern hemisphere show that this year's flu shot was 34.5% effective against hospitalization in high-risk groups during that half of the globe's winter ...

The 2024 flu vaccine omits the "Flu B" strain, which has not circulated since 2020, due to the effects of COVID-19 ...

In contrast, SARS-CoV-2 was a brand new virus that no one had encountered before; therefore, masking and isolation only slowed its transmission, but did not stop it. The absence of B/Yamagata won’t ...